Bioengineered Delivery Systems for Cellular Resilience Research
Next Aevolux Laboratories has developed a biologically derived delivery platform designed for transient and controlled delivery of reprogramming-associated nucleic acids, supporting cellular resilience and longevity-related research.

Development of iPSC-derived extracellular vesicle delivery systems.

Transient expression technologies designed to avoid full pluripotency activation.

Scalable biological transport systems for research and innovation.
Future Development
Next Aevolux Laboratories continues to expand research in biologically derived delivery systems, regenerative science, and next-generation longevity technologies.
Patent Status
Patent Application Pending
Research and development activities are ongoing. Additional patent applications may be pursued as research advances.
NEXT AEVOLUX™
Research • Innovation • Longevity Science
© 2026 Next Aevolux Laboratories. All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.